Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital Warts
Status:
Completed
Trial end date:
2010-07-15
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the effectiveness of destructive therapy for
anogenital warts in combination with the use of Ingaron in comparison with destructive
therapy.